2025 annual financial data
Nektar Therapeutics 2025 Operating margin
Nektar Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -236.77%.
Operating income was -130,770,999 USD and net income was -164,076,000 USD.
Operating cash flow was -208,511,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,232,000 USD
- Operating income
- -130,770,999 USD
- Net income
- -164,076,000 USD
- Operating cash flow
- -208,511,000 USD